Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with NivolumabUgo De Giorgi, Cora N. Sternberg, Manfred Mitterer et al.|Clinical Cancer Research|2019Cited by 240
Inflammatory indexes strongly predict clinical outcome in patients (pts) with metastatic renal cell cancer (mRCC) treated with nivolumab: results from the Italian expanded access program (EAP)Ugo De Giorgi, Cora N. Sternberg, Giuseppe Procopio et al.|Annals of Oncology|2017Cited by 3
Association of body mass index and systemic inflammation index with survival in patients with renal cell cancer treated with nivolumab.Ugo De Giorgi, Cora N. Sternberg, Giuseppe Procopio et al.|Journal of Clinical Oncology|2019Cited by 2